Home > Healthcare > Analytical Instruments > Lab Equipment and Supplies > serum separation gel market
Get a free sample of Serum Separation Gel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Serum Separation Gel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Serum Separation Gel Market size was valued at around USD 7.7 billion in 2023 and is anticipated to grow at a CAGR of 5.9% between 2024 and 2032. Serum separation gel is a specialized substance found in blood collection tubes designed to facilitate the separation of serum from whole blood during centrifugation. Typically composed of gel materials such as silicone or inert polymers, it is positioned between the serum-free media layer and the clot activator or anticoagulant layer within the tube. Centrifuging causes the gel to act as a barrier, enabling the clean separation of serum from blood cells.
The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer, fueling the demand for diagnostic testing and monitoring. For instance, according to World Health Organization (WHO) in 2022, reported that cancer emerged as a prominent contributor to global mortality, claiming approximately 9.7 million lives globally. Thus, the increasing demand for sophisticated diagnostic equipment such as serum separation gel for precise sample handling is projected to persist, driven by the ongoing requirements of healthcare systems on a global scale.
Furthermore, market growth is attributed to multiple factors, including the rising demand for diagnostic, growing technological advancement in blood collection, and growing adoption of point of care testing.
Becton, Dickinson and Company, BIOSIGMA S.p.A., Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l. and Greiner AG among others.
North America serum separation gel market held a revenue share of 40.6% in 2023 and is predicted to witness substantial growth by 2032, driven by a well-developed healthcare infrastructure, including state-of-the-art clinical laboratories.
The blood banks end-use segment in the serum separation gel industry accounted for USD 3.4 billion in 2023 and is set to gain traction by 2032, owing to the ability to improve the safety and efficacy of blood products collected and processed by blood banks.
The serum separation gel industry crossed USD 7.7 billion in 2023 and is estimated to reach over USD 13 billion by 2032, driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.